207 related articles for article (PubMed ID: 23862745)
1. The value of surface enhanced laser desorption/ionization-time of flight mass spectrometry at the diagnosis of non-small cell lung cancer: a systematic review.
Jiang F; Zhou XY; Huang J
Technol Cancer Res Treat; 2014 Apr; 13(2):109-17. PubMed ID: 23862745
[TBL] [Abstract][Full Text] [Related]
2. Potential role of proteomics in the diagnosis of lymphoma: a meta-analysis.
Hu QY; Su J; Jiang H; Wang LL; Jia YQ
Int J Lab Hematol; 2013 Aug; 35(4):367-78. PubMed ID: 23216964
[TBL] [Abstract][Full Text] [Related]
3. MicroRNAs in body fluids as biomarkers for non-small cell lung cancer: a systematic review.
Huang Y; Hu Q; Deng Z; Hang Y; Wang J; Wang K
Technol Cancer Res Treat; 2014 Jun; 13(3):277-87. PubMed ID: 24066954
[TBL] [Abstract][Full Text] [Related]
4. Application of serum SELDI proteomic patterns in diagnosis of lung cancer.
Yang SY; Xiao XY; Zhang WG; Zhang LJ; Zhang W; Zhou B; Chen G; He DC
BMC Cancer; 2005 Jul; 5():83. PubMed ID: 16029516
[TBL] [Abstract][Full Text] [Related]
5. Study of distinct protein profiles for early diagnosis of NSCLC using LCM and SELDI-TOF-MS.
Yang S; Nan Y; Tian Y; Zhang W; Zhou B; Bu L; Huo S; Chen G; Yu J; Zheng S
Med Oncol; 2008; 25(4):380-6. PubMed ID: 18300004
[TBL] [Abstract][Full Text] [Related]
6. Performance of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS) in diagnosis of ovarian cancer: a systematic review and meta-analysis.
Li K; Pei Y; Wu Y; Guo Y; Cui W
J Ovarian Res; 2020 Jan; 13(1):6. PubMed ID: 31924227
[TBL] [Abstract][Full Text] [Related]
7. [Application of serum surface-enhanced laser desorption/ionization proteomic patterns in distinguishing non-small cell lung cancer patients from healthy people].
Yang SY; Xiao XY; Zhang WG; Sun XZ; Zhang LJ; Zhang W; Zhou B; Yang DC; He DC
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Jan; 29(1):31-4. PubMed ID: 16638298
[TBL] [Abstract][Full Text] [Related]
8. [Comparative study of protein markers in serum and bronchoalveolar lavage fluid from patients with lung cancer by surface-enhanced laser desorption ionization time of flight mass spectrometry].
Zhou JH; Liu GN; Huang SM; Zhong XN; Su H; Zhou Y
Zhonghua Jie He He Hu Xi Za Zhi; 2011 Apr; 34(4):274-7. PubMed ID: 21609611
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry.
Navaglia F; Fogar P; Basso D; Greco E; Padoan A; Tonidandel L; Fadi E; Zambon CF; Bozzato D; Moz S; Seraglia R; Pedrazzoli S; Plebani M
Clin Chem Lab Med; 2009; 47(6):713-23. PubMed ID: 19426140
[TBL] [Abstract][Full Text] [Related]
10. Identification of candidate molecular markers predicting chemotherapy resistance in non-small cell lung cancer.
Han M; Liu Q; Yu J; Zheng S
Clin Chem Lab Med; 2010 Jun; 48(6):863-7. PubMed ID: 20345233
[TBL] [Abstract][Full Text] [Related]
11. [Use of laser capture microdissection and surface-enhanced laser desorption ionization time-of-flight mass spectrometry to screen differential proteins in lung adenocarcinoma and lung squamous carcinoma].
Tian YX; Yang SY; Nan YD; Zhang W; Zhou B; Bu LN; Huo SF; Yu JK; Zheng S
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(3):145-8. PubMed ID: 18361807
[TBL] [Abstract][Full Text] [Related]
12. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
Han KQ; Huang G; Gao CF; Wang XL; Ma B; Sun LQ; Wei ZJ
Am J Clin Oncol; 2008 Apr; 31(2):133-9. PubMed ID: 18391596
[TBL] [Abstract][Full Text] [Related]
13. [Application of laser capture microdissection and surface-enhanced laser desorption ionization time-of-flight mass spectrometry to screen biomarkers for early diagnosis of lung adenocarcinoma].
Tian YX; Yang SY; Nan YD; Zhang W; Yu JK; Zheng S
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Jan; 40(1):157-61. PubMed ID: 19292069
[TBL] [Abstract][Full Text] [Related]
14. Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease.
Zinkin NT; Grall F; Bhaskar K; Otu HH; Spentzos D; Kalmowitz B; Wells M; Guerrero M; Asara JM; Libermann TA; Afdhal NH
Clin Cancer Res; 2008 Jan; 14(2):470-7. PubMed ID: 18223221
[TBL] [Abstract][Full Text] [Related]
15. Application of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry coupled with an artificial neural network model for the diagnosis of hepatocellular carcinoma.
Hu Q; Huang Y; Wang Z; Tao H; Liu J; Yan L; Wang K
Hepatogastroenterology; 2012 Sep; 59(118):1902-6. PubMed ID: 22193438
[TBL] [Abstract][Full Text] [Related]
16. SELDI-TOF MS proteinchip technology for screening of serum markers of HBV-induced hepatocellular carcinoma.
Geng X; Wang F; Li YG; Zhu GP; Zhang WM
J Exp Clin Cancer Res; 2007 Dec; 26(4):505-8. PubMed ID: 18365545
[TBL] [Abstract][Full Text] [Related]
17. Identification of serum biomarkers for lung cancer using magnetic bead-based SELDI-TOF-MS.
Song QB; Hu WG; Wang P; Yao Y; Zeng HZ
Acta Pharmacol Sin; 2011 Dec; 32(12):1537-42. PubMed ID: 22019958
[TBL] [Abstract][Full Text] [Related]
18. [Preliminary study of MALDI-TOF mass spectrometry-based screening of patients with the NSCLC serum-specific peptides].
An J; Tang C; Wang N; Liu Y; Guo W; Li X; Wang Z; He K; Liu X
Zhongguo Fei Ai Za Zhi; 2013 May; 16(5):233-9. PubMed ID: 23676979
[TBL] [Abstract][Full Text] [Related]
19. Detection and identification of potential biomarkers of non-small cell lung cancer.
Yang Y; Zhao S; Fan Y; Zhao F; Liu Q; Hu W; Liu D; Fan K; Wang J; Wang J
Technol Cancer Res Treat; 2009 Dec; 8(6):455-66. PubMed ID: 19925029
[TBL] [Abstract][Full Text] [Related]
20. A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry.
Liu XP; Shen J; Li ZF; Yan L; Gu J
Cancer Invest; 2006 Dec; 24(8):747-53. PubMed ID: 17162557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
